Newsroom Stories

Research in animals led by Washington University and the Roslin Institute in Scotland shows that supplying a vital missing enzyme helps to improve CLN1 disease, a rare but fatal brain disorder.

Philip H. Dybvig, a banking and finance expert at Washington University in St. Louis, is one of three economists to share the 2022 Nobel Prize in economic sciences, the Royal Swedish Academy of Sciences announced Monday, Oct. 10.

The newly formed Ann W. and Spencer T. Olin-Chancellor’s Fellowship will merge two long-standing programs — the Spencer T. and Ann W. Olin Fellowship for Women in Graduate Study and the Chancellor’s Graduate Fellowship — into a single program designed to attract graduate students representing a variety of diverse backgrounds.

Washington University in St. Louis has announced a transformative fundraising initiative that aims not only to increase financial resources for students at every level of need, including middle-income students, but also to provide a “best-in-class” experience for all students to learn, develop and flourish while on campus and beyond.

New Olin Business School research suggests those touched by the sometimes devastating effects of the COVID-19 pandemic are now more likely to recognize sources of inequality and, in turn, advocate for greater equality in the United States.

Fashion icon Diane von Furstenberg will discuss her life and work in a free talk at 5:30 p.m. Wednesday, Oct. 12, in Graham Chapel. The event is hosted by the Saint Louis Fashion Fund, in partnership with Caleres and WashU’s Sam Fox School of Design & Visual Arts.

The Spencer T. and Ann W. Olin Fellowship for Women in Graduate Study at Washington University in St. Louis will host the 2022 “She Leads” symposium Oct. 21 in Knight Hall’s Emerson Auditorium.

Researchers at Washington University School of Medicine have identified a pathway in the brains of mice that is activated when the animals see other mice scratching. They found that this so-called “contagious itching” is controlled through a visual pathway that operates independently of the visual cortex.

Washington University has licensed the rights to develop, manufacture and commercialize its proprietary COVID-19 nasal vaccine in the United States, Europe and Japan to Ocugen Inc., a U.S.-based biotechnology company.

As a young sculptor, Chakaia Booker collected scraps of ruined tires from the streets of lower Manhattan. The material was ubiquitous, malleable and symbolically resonant. Now “Shaved Portions,” one of Booker’s largest and most ambitious projects to date, has been installed on WashU’s Danforth Campus.